A cluster of mucormycosis infections in hematology patients: Challenges in investigation and control of invasive mold infections in high-risk patient populations

Diagnostic Microbiology and Infectious Disease

Volumn 71, Issue 1, 2011, Pages 72-80

  Llata, Eloisa ^a,b   Blossom, David B ^a,b,e   Khoury, H Jean ^c   Rao, Carol Y ^a,b   Wannemuehler, Kathleen A ^b   Noble Wang, Judith ^a   Langston, Amelia A ^c   Ribner, Bruce S ^c   Lyon, G Marshall ^c   Arnold, Kathryn E ^d   Jackson, Deonne R ^b,c   Brandt, Mary E ^b   Chiller, Tom M ^b   Balajee, S Arunmozhi ^b   Srinivasan, Arjun ^a   Magill, Shelley S ^a,b  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Georgia Division of Public Health   (United States)

^e ID Consultants   (United States)

Author keywords

Fungal infection; Mucormycosis; Outbreak; Zygomycosis

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; FLUCONAZOLE; MICAFUNGIN; POSACONAZOLE; VORICONAZOLE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CLINICAL ARTICLE; DATA BASE; ENVIRONMENT; FEMALE; FUNGUS CULTURE; HEMATOLOGIC DISEASE; HIGH RISK PATIENT; HOSPITAL; HUMAN; INFECTION CONTROL; MALE; MICROBIOLOGY; MORTALITY; MUCORMYCOSIS; MYCOSIS; NEUTROPENIA; PATHOLOGY; PRIORITY JOURNAL; REFRACTORY PERIOD;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ANTIFUNGAL AGENTS; CASE-CONTROL STUDIES; CROSS INFECTION; DISEASE OUTBREAKS; ENVIRONMENT, CONTROLLED; FEMALE; FOLLOW-UP STUDIES; HEMATOLOGIC DISEASES; HUMANS; MALE; MIDDLE AGED; MUCORMYCOSIS;

EID: 80051662459     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2010.12.022     Document Type: Article

References (32)

1. Abzug MJ, Gardner S, Glode MP, Cymanski M, Roe MH, Odom LF Heliport-associated nosocomial mucormycoses. Infect Control Hosp Epidemiol 1992, 13:325-326.
2. Alsuwaida K Primary cutaneous mucormycosis complicating the use of adhesive tape to secure the endotracheal tube. Can J Anaesth 2002, 49:880-882.
3. American Institute of Architects and the Facilities Guidelines Institute Guidelines for design and construction of health care facilities 2006, American Institute of Architects Press, Washington, D.C.
4. Antoniadou A Outbreaks of zygomycosis in hospitals. Clin Microbiol Infect 2009, 15(Suppl 5):55-59.
5. Centers for Disease Control and Prevention (CDC) (2000) Guidelines for preventing opportunistic infections among hematopoietic cell transplant recipients. MMWR Recomm Rep 49(RR-10):1-125,CE1-7.
6. Centers for Disease Control and Prevention (CDC) Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 2003, 52:1-42.
7. Cheng VC, Chan JF, Ngan AH, To KK, Leung SY, Tsoi HW, Yam WC, Tai JW, Wong SS, Tse H, Li IW, Lau SK, Woo PC, Leung AY, Lie AK, Liang RH, Que TL, Ho PL, Yuen KY Outbreak of intestinal infection due to Rhizopus microsporus. J Clin Microbiol 2009, 47:2834-2843.
8. Christiaens G, Hayette MP, Jacquemin D, Melin P, Mutsers J, De Mol P An outbreak of Absidia corymbifera infection associated with bandage contamination in a burns unit. J Hosp Infect 2005, 61:88.
9. Courtney R, Wexler D, Radwanski E, Lim J, Laughlin M Effect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adults. Br J Clin Pharmacol 2004, 57:218-222.
10. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Marr KA, Muñoz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C, Wingard JR, Zaoutis T, Bennett JE Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008, 46:1813-1821. European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group, National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus GroupNational Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.
11. Garner D, Machin K Investigation and management of an outbreak of mucormycosis in a paediatric oncology unit. J Hosp Infect 2008, 70:53-59.
12. Greenberg RN, Mullane K, van Burik JA Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother 2006, 50:126-133.
13. Imhof A, Balajee SA, Fredricks DN, Englund JA, Marr KA Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole. Clin Infect Dis 2004, 39:743-746.
14. Kontoyiannis DP, Lionakis MS, Lewis RE, Chamilos G, Healy M, Perego C, Safdar A, Kantarjian H, Champlin R, Walsh TJ, Raad II Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J Infect Dis 2005, 191:1350-1360.
15. Kontoyiannis DP, Marr KA, Park BJ, Alexander BD, Anaissie EJ, Walsh TJ, Ito J, Andes DR, Baddley JW, Brown JM, Brumble LM, Freifeld AG, Hadley S, Herwaldt LA, Kauffman CA, Knapp K, Lyon GM, Morrison VA, Papanicolaou G, Patterson TF, Perl TM, Schuster MG, Walker R, Wannemuehler KA, Wingard JR, Chiller TM, Pappas PG Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) database. Clin Infect Dis 2010, 50:1091-1100.
16. Kontoyiannis DP, Wessel VC, Bodey GP, Rolston KV Zygomycosis in the 1990s in a tertiary-care cancer center. Clin Infect Dis 2000, 30:851-856.
17. LeMaile-Williams M, Burwell LA, Salisbury D, Noble-Wang J, Arduino M, Lott T, Brandt ME, Iiames S, Srinivasan A, Fridkin SK Outbreak of cutaneous Rhizopus arrhizus infection associated with karaya ostomy bags. Clin Infect Dis 2006, 43:e83-e88.
18. Levy V, Rio B, Bazarbachi A, Hunault M, Delmer A, Zittoun R, Blanc V, Wolff M Two cases of epidemic mucormycosis infection in patients with acute lymphoblastic leukemia. Am J Hematol 1996, 52:64-65.
19. Maravi-Poma E, Rodriguez-Tudela JL, de Jalon JG, Manrique-Larralde A, Torroba L, Urtasun J, Salvador B, Montes M, Mellado E, Rodríguez-Albarrán F, Pueyo-Royo A Outbreak of gastric mucormycosis associated with the use of wooden tongue depressors in critically ill patients. Intensive Care Med 2004, 30:724-728.
20. Marr KA, Carter RA, Crippa F, Wald A, Corey L Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002, 34:909-917.
21. Marty FM, Cosimi LA, Baden LR Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants. N Engl J Med 2004, 350:950-952.
22. Mitchell SJ, Gray J, Morgan ME, Hocking MD, Durbin GM Nosocomial infection with Rhizopus microsporus in preterm infants: association with wooden tongue depressors. Lancet 1996, 348:441-443.
23. Ramos A, Cuervas-Mons V, Noblejas A, Baños I, Duran P, Marcos R, Sánchez-Turrión V, Jiménez M, Arellano B, Corbacho C, Sánchez-Romero I Breakthrough rhinocerebral mucormycosis in a liver transplant patient receiving caspofungin. Transplant Proc 2009, 41:1972-1975.
24. Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, Sein M, Sein T, Chiou CC, Chu JH, Kontoyiannis DP, Walsh TJ Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005, 41:634-653.
25. Siwek GT, Dodgson KJ, de Magalhaes-Silverman M, Bartelt LA, Kilborn SB, Hoth PL, Diekema DJ, Pfaller MA Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis. Clin Infect Dis 2004, 39:584-587.
26. Suzuki K, Sugawara Y, Sekine T, Nakase K, Katayama N Breakthrough disseminated zygomycosis induced massive gastrointestinal bleeding in a patient with acute myeloid leukemia receiving micafungin. J Infect Chemother 2009, 15:42-45.
27. Trifilio SM, Bennett CL, Yarnold PR, McKoy JM, Parada J, Mehta J, Chamilos G, Palella F, Kennedy L, Mullane K, Tallman MS, Evens A, Scheetz MH, Blum W, Kontoyiannis DP Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy. Bone Marrow Transplant 2007, 39:425-429.
28. Vigouroux S, Morin O, Moreau P, Méchinaud F, Morineau N, Mahé B, Chevallier P, Guillaume T, Dubruille V, Harousseau JL, Milpied N Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required. Clin Infect Dis 2005, 40:e35-e37.
29. Vonberg RP, Gastmeier P Nosocomial aspergillosis in outbreak settings. J Hosp Infect 2006, 63:246-254.
30. Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Segal BH, Steinbach WJ, Stevens DA, van Burik JA, Wingard JR, Patterson TF, Infectious Diseases Society of America Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008, 46:327-360.
31. Warris A, Verweij PE Clinical implications of environmental sources for Aspergillus. Med Mycol 2005, 43(Suppl 1):S59-S65.
32. Yokoe D, Casper C, Dubberke E, Lee G, Muñoz P, Palmore T, Sepkowitz K, Young JA, Donnelly JP Infection prevention and control in health-care facilities in which hematopoietic cell transplant recipients are treated. Bone Marrow Transplant 2009, 44:495-507. Center for International Blood and Marrow Transplant Research, National Marrow Donor ProgramNational Marrow Donor Program, European Blood and Marrow Transplant GroupEuropean Blood and Marrow Transplant Group, American Society of Blood and Marrow TransplantationAmerican Society of Blood and Marrow Transplantation, Canadian Blood and Marrow Transplant GroupCanadian Blood and Marrow Transplant Group, Infectious Disease Society of AmericaInfectious Disease Society of America, Society for Healthcare Epidemiology of AmericaSociety for Healthcare Epidemiology of America, Association of Medical Microbiology and Infectious Diseases CanadaAssociation of Medical Microbiology and Infectious Diseases Canada, Centers for Disease Control and PreventionCenters for Disease Control and Prevention.